Novartis A.G . NVS reported first-quarter 2015 earnings of 96 cents per share, down 3% from the year-ago period. Core earnings per share came in at $1.33, down from $1.35 in the year-ago period but above the Zacks Consensus Estimate of $1.09. ... Zacks.com, 2 days ago
Antihypertensive Therapeutics in Major Developed Markets to 2020 - Increased Uptake of Combination Therapies to Offset Effects of Key Patent Expiries
/PRNewswire/ -- Summary GBI Research, the leading business intelligence provider, has released its latest research, '' '', which provides in-depth analysis of hypertension therapeutics market within the eight major geographies of the US, the top ...Sys-Con Media, 1 week ago Research Report - Breast Cancer Therapeutics in Major Developed Market... Creative Times, 1 month ago Market Overview - Antihypertensive Therapeutics in Major Developed Industry 2020: Radiant Insights, Inc Press Release Ping, 1 month ago Cardiovascular Drugs Market - Global Industry Size, Share, Trends Analysis to 2020 Digital Journal, 1 month ago
Research and Markets (http://www.researchandmarkets.com/research/vzs98b/valsartan) has announced the addition of the "Valsartan - Comprehensive patent search" report to their offering. Imagine having your own team of pharmaceutical patent experts at ...Individual.com, 1 month ago Research and Markets: Valsartan - 2015 Comprehensive Patent Search TeleTrader.com, 1 month ago
on your WebpageAdd Widget >Get your members hooked!